A Flow and Metabolism-Based Drug Screening Platform for Liquid Patient Leukemia Samples

Alicia J. Kaestli(Whitehead Institute for Biomedical Research), Kasper Renggli(Vectura (Germany)), Christian Lohasz(ETH Zurich), Andreas Hierlemann(ETH Zurich), Yonghong Huang(Jiangsu University), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Brice Mouttet(University Children's Hospital Zurich), Martina De Geus, Beat Bornhäuser(University Children's Hospital Zurich)
Unknown
January 1, 2017
Cited by 0

Related Papers

Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
|Proceedings of the National Academy of Sciences|2011|1.1k
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
|Blood|2009|347
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
|Journal of Clinical Investigation|2010|311
<i>IKZF1</i><sup>plus</sup>Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
|Journal of Clinical Oncology|2018|304
Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7
|Science Advances|2019|274